Copyright
©The Author(s) 2015.
World J Gastroenterol. Sep 28, 2015; 21(36): 10435-10442
Published online Sep 28, 2015. doi: 10.3748/wjg.v21.i36.10435
Published online Sep 28, 2015. doi: 10.3748/wjg.v21.i36.10435
Table 3 Adverse events during treatment
Hybrid therapy | Sequential therapy | P value | |
Compliance, n (%) | 84 (97.7) | 83 (97.6) | 0.99 |
Side effects, n (%) | 52 (59) | 60 (69) | 0.22 |
Diarrhea | 16/1/11 | 15/0/0 | 0.42 |
Constipation | 1/0/0 | 2/0/0 | 0.50 |
Anorexia | 0 | 1/0/0 | 0.70 |
Nausea | 4/1/0 | 9/0/1 | 0.92 |
Vomiting | 5/2/0 | 3/1/0 | 0.57 |
Abdominal pain | 5/0/0 | 9/0/0 | 0.87 |
Skin rash | 3/2/0 | 1/2/0 | 0.74 |
Headache | 9/1/1 | 16/1/1 | 0.41 |
Dizziness | 6/1/0 | 9/0/0 | 0.70 |
Bitter taste | 25/6/0 | 36/3/0 | 0.17 |
Fatigue | 3/0/0 | 4/0/0 | 0.30 |
-
Citation: Chen KY, Lin TJ, Lin CL, Lee HC, Wang CK, Wu DC. Hybrid
vs sequential therapy for eradication ofHelicobacter pylori in Taiwan: A prospective randomized trial. World J Gastroenterol 2015; 21(36): 10435-10442 - URL: https://www.wjgnet.com/1007-9327/full/v21/i36/10435.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i36.10435